(Q42746699)

6 November 2017

0 references

Promoting a new brain tumor mutation: TERT promoter mutations in CNS tumors (English)

1 reference

6 November 2017

1 reference

Zachary J Reitman

1

0 references

author name string

Christopher J Pirozzi

series ordinal

2

1 reference

PMC publication ID

3888653

6 November 2017

Hai Yan

series ordinal

3

1 reference

6 November 2017

1 December 2013

1 reference

6 November 2017

Acta Neuropathologica

1 reference

6 November 2017

126

1 reference

6 November 2017

6

1 reference

6 November 2017

789-792

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-013-1207-5

6 November 2017

0 references

cites work

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

TERT promoter mutations in primary and secondary glioblastomas.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Highly recurrent TERT promoter mutations in human melanoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

TERT promoter mutations in familial and sporadic melanoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

Telomerase activity in human brain tumours.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3888653

10.1007/S00401-013-1207-5

16 August 2018

Identifiers

DOI

1 reference

6 November 2017

1 reference

PMC publication ID

3888653

6 November 2017

PubMed publication ID

24217890

1 reference

PMC publication ID

3888653